focus -WSS

focus

author：explore 2025-10-01 05:38:58 - browse：9

Sammy Kimball for STAT

Can Novavax finally get it right? What’s a “triple-G” drug? And is Novo Nordisk losing ground?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Our colleague Elaine Chen joins us to explain how the era of Wegovy could be short-lived in light of powerful new weight-loss medicines from Eli Lilly. Then, John Jacobs, the new CEO of Novavax, stops by to explain his plan to right the ship at a company that has struggled to make the most of its potent Covid-19 vaccine.

For more on what we cover, here’s the news on Lilly; here’s more on Novavax; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Guidelines to prevent youth baseball injuries need more muscle
Next article： New definition of a human embryo proposed amid rapid advances

leisure time

WSS

ActiGraph execs on goal of drug approvals with digital endpoints

As Maui death toll rises, number of missing remains unclear

Why medical students are struggling with mental health

A neonatal nurse in a British hospital has been found guilty of killing 7 babies

Anthos stroke drug appears safer than common blood thinner

A daunting task: navigating dual Medicare, Medicaid eligibility

hotspot

focus

focus

Walensky prepares to leave CDC — and Congress — behind

Hilary may become 1st tropical storm to make landfall in California in 84 years

As demand for Covid shots wanes, Moderna seeks its next success

U.K. considers world's first use of meningitis vaccine to address gonorrhea

After affirmative action ruling, medical educators look to 'holistic review'

Lung cancer is America's deadliest cancer. Yet so few get screened

Walensky prepares to leave CDC — and Congress — behind

The boys, now 6, who are gene therapy’s ‘edge case’ problem

Walensky prepares to leave CDC — and Congress — behind

Why medical students are struggling with mental health

Wikipedia

CRISPR pioneers react to Casgevy, first gene

Hilary may become 1st tropical storm to make landfall in California in 84 years

In key trial, Verve's treatment lowers cholesterol levels in patients

Readout LOUD podcast: A CRISPR milestone, biotech mixology

Hilary may become 1st tropical storm to make landfall in California in 84 years

PBM reforms clear House panel

leisure time

hotspot

hotspot

explore